Global Contract Manufacturing Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2030 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>Globaler Markt für Auftragsfertigung, nach Produkt (Herstellung pharmazeutischer Produkte und medizinischer Geräte), nach Endverbraucher (Pharmaunternehmen, Biotechnologieunternehmen, Biopharmaunternehmen, Hersteller medizinischer Geräte, Erstausrüster und Forschungsinstitute), nach Vertriebskanal (Einzelhandel, direkte Ausschreibung und andere) – Branchentrends und Prognosen bis 2030.
Analyse und Einblicke zum Markt für Auftragsfertigung
Der globale Auftragsfertigungsmarkt wird von Faktoren wie steigenden technischen Fortschritten und Kosteneffizienz von Pharma- und Pipeline-Produkten angetrieben, was die Nachfrage steigert, während steigende Investitionen in Forschung und Entwicklung zum Marktwachstum führen. Derzeit sind die Gesundheitsausgaben in Industrie- und Schwellenländern gestiegen, was den Herstellern voraussichtlich einen Wettbewerbsvorteil bei der Entwicklung neuer und innovativer Produkte verschaffen wird.
Auftragsfertigung ist ein Vertrag zwischen einem Unternehmen und einem Hersteller, der die Herstellung einer bestimmten Anzahl von Komponenten oder Produkten für das Unternehmen in einem bestimmten Zeitraum vorsieht. Die hergestellten Waren werden unter dem Etikett oder der Marke des Unternehmens verkauft. Dies wird als Eigenmarkenfertigung bezeichnet. Dies wird häufig auch als Outsourcing bezeichnet, wenn es länderübergreifend erfolgt. Hersteller erbringen ihre Leistungen auf der Grundlage ihrer eigenen Designs, Formeln und Spezifikationen, sofern der Kunde keine eigenen bereitstellt. Sie stellen diese Produkte für jeden her, mit dem sie einen Vertrag abgeschlossen haben, sogar für konkurrierende Unternehmen.
Einer der Hauptfaktoren, die das Wachstum des Auftragsfertigungsmarktes vorantreiben, ist die weltweit steigende Nachfrage im Bereich Medizinprodukte und Pharmazeutika. Die fortlaufende klinische Studienforschung, die von mehreren Unternehmen zur besseren Diagnose durchgeführt wird, führt zu einer Marktexpansion. Der Markt wird auch durch den zunehmenden technologischen Fortschritt und die Kosteneffizienz beeinflusst. Das Risiko vertraulicher Informationen und strenger Vorschriften können jedoch im Prognosezeitraum als einschränkende Faktoren für den globalen Auftragsfertigungsmarkt wirken.
Auf der anderen Seite bieten Patentabläufe und die steigende Nachfrage nach Generika, steigende Ausgaben für die Gesundheitsinfrastruktur und strategische Initiativen wichtiger Marktteilnehmer Chancen für das Wachstum des Marktes. Das Risiko des geistigen Eigentums und die steigende Zahl von Pharmaunternehmen, die ihre eigenen Produktionseinheiten aufbauen, können jedoch den globalen Auftragsfertigungsmarkt vor Herausforderungen stellen.
Die Nachfrage nach Auftragsfertigung wird weltweit steigen, da immer mehr Patienten in Richtung Point-of-Care-Diagnostik tendieren . Verschiedene Unternehmen ergreifen Initiativen, die schrittweise zum Wachstum des Marktes führen.
Der globale Markt für Auftragsfertigung ist unterstützend und zielt darauf ab, den Fertigungsaufwand von Gesundheitsorganisationen zu reduzieren. Data Bridge Market Research analysiert, dass der globale Markt für Auftragsfertigung im Prognosezeitraum von 2023 bis 2030 mit einer durchschnittlichen jährlichen Wachstumsrate von 6,2 % wachsen wird.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2023 bis 2030 |
|
Basisjahr |
2022 |
|
Historische Jahre |
2021 (anpassbar auf 2015–2020) |
|
Quantitative Einheiten |
Umsatz in Millionen USD, Preise in USD |
|
Abgedeckte Segmente |
Nach Produkt (Herstellung pharmazeutischer Produkte und medizinischer Geräte), nach Endverbraucher (Pharmaunternehmen, Biotechnologieunternehmen, Biopharmaunternehmen, Hersteller medizinischer Geräte, Erstausrüster und Forschungsinstitute), nach Vertriebskanal (Einzelhandel, Direktausschreibung und andere) |
|
Abgedeckte Länder |
USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Spanien, Niederlande, Russland, Schweiz, Türkei, Belgien, Restliches Europa, China, Japan, Indien, Südkorea, Australien, Singapur, Thailand, Malaysia, Indonesien, Philippinen, Restlicher Asien-Pazifik-Raum, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Ägypten, Israel, Restlicher Naher Osten und Afrika |
|
Abgedeckte Marktteilnehmer |
Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH. und Catalent, Inc. unter anderem |
Dynamik der globalen Auftragsfertigung
Marktdefinition
Auftragsfertigung auf internationalen Märkten wird in Situationen verwendet, in denen ein Unternehmen seine Produkte von einem anderen Unternehmen in einem anderen Land fertigen lässt; dies wird auch als internationales Subcontracting oder internationales Outsourcing bezeichnet. Das Unternehmen stellt dem Hersteller alle Spezifikationen und gegebenenfalls auch die für den Produktionsprozess erforderlichen Materialien zur Verfügung. Diese Art von Vertrag legt die Anforderungen fest, die der Hersteller hinsichtlich der Qualität der Produkte, der Zertifizierung, der Mengen, der Lieferbedingungen und -termine usw. erfüllen muss. Er legt auch Richtlinien für die Inspektion und Prüfung der Produkte fest, die vom Unternehmen, das die Fertigung beauftragt, oder von seinen eigenen Kunden festgelegt werden. Darüber hinaus werden darin auch Auftragsänderungen sowie Garantien und Entschädigungen im Falle eines Vertragsbruchs festgelegt. Da es sich bei diesem Prozess im Wesentlichen um das Outsourcing der Produktion auf ausländischen Märkten an einen Partner handelt, der das Endprodukt unter eigener Marke vertreibt, gibt es eine Reihe verschiedener Unternehmen und Branchen, die diese Art von Vertrag nutzen können.
Treiber
- Wirtschaftlichkeit für die produzierenden Unternehmen
Die zeitaufwändige Herstellung und ineffektive Produktion verschiedener Dinge sowie das Management sind große Belastungen für Organisationen des öffentlichen und privaten Sektors. Sie sind auch für die Bewältigung komplexer Herausforderungen von entscheidender Bedeutung, da eine einzelne Organisation den Wandel und manchmal die erforderlichen Ergebnisse weniger effektiv vorantreiben kann. Die Auftragsfertigungsunternehmen werden sowohl für den staatlichen als auch den privaten Sektor wachsende Chancen darstellen.
Die steigende Nachfrage nach Auftragsfertigung mit verbesserter Genauigkeit und weniger Zeitdruck zwingt die wichtigsten Akteure zu strategischen Initiativen. Durch die Übernahme der Auftragsfertigung werden die Gemeinkosten frei, die für Investitionen in Maschinen, Material und zusätzliche Arbeitskräfte erforderlich sind, wodurch der Produktionsprozess vereinfacht und die Lieferkette durch die Senkung der Gesamtkosten rationalisiert wird.
Die großen Marktteilnehmer investieren jedoch viel Kapital in die Fertigung, um die Anforderungen ihrer Endverbraucher zu erfüllen. Die Vertragshersteller sind an der Entwicklung und Umsetzung der Strategien beteiligt, indem sie die Produktionskosten dieser Unternehmen senken. Vertragsherstellerdienste für andere Unternehmen sorgen auch für Effizienz und optimale Ressourcennutzung, indem sie effektive Arbeitskräfte, strategische Intelligenz oder Arbeitsressourcen einsetzen, die im Produktionszyklus erforderlich sind.
- Anstieg des technologischen Fortschritts in der Auftragsfertigung
Die zeitnahe Markteinführung eines neuen Medikaments erfordert aufgrund der gestiegenen Nachfrage in der Pharmaindustrie erhebliche Investitionen in die Produktion. Fortgeschrittene Technologien und Fähigkeiten sind zwingend erforderlich, da manche Medikamente komplexe Formeln haben und bei der Massenproduktion spezielle Geräte und Techniken erfordern.
Der Einsatz innovativer Technologien wie maschinelles Lernen, Big Data und künstliche Intelligenz zur Entwicklung von Arzneimitteln oder zur Herstellung medizinischer Geräte wird für eine schnelle und zügige Fertigung in Betracht gezogen. Diese technischen Fortschritte helfen auch bei der Massenproduktion und Skalierbarkeit in kurzer Zeit.
Allerdings prüfen oder überwachen Pharmaunternehmen üblicherweise die Produktions- und Lieferprozesse ihrer Auftragsfertigungsorganisationen, um den Herstellungsprozess mithilfe einer Fernverfolgung in Echtzeit zu überwachen.
Gelegenheiten
- Steigende Ausgaben für den Ausbau der Gesundheitsinfrastruktur
Die Infrastruktur ist eine wichtige Säule, die das grundlegende Ziel unterstützt, verbesserte Standards der Pflege und des Wohlbefindens aller Patienten sowie eine gute Erfahrung im Gesundheitssystem zu fördern. Parallel dazu müssen das Gesundheitssystem und das Personal eine wirksame Gesundheitsförderung, Prävention und Selbstversorgung der gesamten Bevölkerung unterstützen. Die Infrastruktur muss das Krankenhaus als Zentrum für akute und stationäre Versorgung in das umfassendere Gesundheitssystem integrieren und die sieben Bereiche hochwertige Patientenerfahrung, Wirksamkeit, Effizienz, Aktualität, Sicherheit, Gerechtigkeit und Nachhaltigkeit unterstützen. Die Infrastruktur umfasst die gebaute Umgebung und unterstützende Elemente: Ausrüstung, Zugang, Informationstechnologie (IT), Systeme und Prozesse, Nachhaltigkeitsinitiativen und Personal.
Allerdings treiben die steigenden Ausgaben für den Ausbau der Gesundheitsinfrastruktur das Wachstum des globalen Auftragsfertigungsmarktes im Prognosezeitraum voran.
Einschränkungen/Herausforderungen
- Immer mehr Pharmaunternehmen eröffnen Produktionsstätten
Die meisten Pharmaunternehmen bauen Produktionsstätten, um pharmazeutische Produkte herzustellen und so Kosten zu senken. Die Hersteller konzentrieren sich stärker auf die Einführung fortschrittlicher Technologien und den Digitalisierungsprozess. Die Pharmaindustrie ist auch mit Umbrüchen aufgrund neuer Geschäftsmodelle und einer stärkeren Fokussierung der Bevölkerung auf personalisierte Medikamente und Behandlungen konfrontiert. Daher ist die Nachfrage nach personalisierter Pflege hoch. Auch die Berufsprofile ändern sich: Einige Arbeitsplätze verschwinden aufgrund der Automatisierung, während völlig neue Arbeitsplätze entstehen.
Daher könnte die steigende Zahl der Pharmaunternehmen, die ihre Produktionseinheiten aufbauen, im Prognosezeitraum eine Herausforderung für das Wachstum des globalen Auftragsfertigungsmarktes darstellen.
Jüngste Entwicklungen
- Im Oktober 2021 hatte Boehringer Ingelheim International GmbH seine hochmoderne biopharmazeutische Produktionsanlage Large Scale Cell Culture (LSCC) in Wien, Österreich, mit einem Investitionsvolumen von mehr als 700 Millionen Euro eingeweiht, was die größte Einzelinvestition in der Unternehmensgeschichte darstellt.
- Im März 2023 gab Evonik Industries AG die Eröffnung einer neuen GMP-Anlage zur Herstellung von Lipiden für fortschrittliche pharmazeutische Arzneimittelverabreichungsanwendungen bekannt. Die Lipid-Startanlage befindet sich am Standort des Unternehmens in Hanau, Deutschland, und versorgt Kunden mit Lipidmengen, die für die klinische und kommerzielle Produktion im kleinen Maßstab benötigt werden.
Globale Marktsegmentierung für Auftragsfertigung
Der globale Markt für Auftragsfertigung ist in drei wichtige Segmente unterteilt, basierend auf Produkt, Endnutzer und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen bei der Analyse von Wachstumsnischen und Strategien zur Marktbearbeitung und bestimmt Ihre wichtigsten Anwendungsbereiche und die Unterschiede in Ihren Zielmärkten.
Produkt
- Herstellung medizinischer Geräte
- Herstellung pharmazeutischer Produkte
Auf Produktbasis ist der globale Markt für Auftragsfertigung in die Herstellung medizinischer Geräte und die Herstellung pharmazeutischer Produkte segmentiert.
Endbenutzer
- Pharmaunternehmen
- Biotechnologie-Unternehmen
- Biopharma-Unternehmen
- Hersteller medizinischer Geräte
- Erstausrüster
- Forschungsinstitute
Auf der Grundlage des Endverbrauchers ist der globale Markt für Auftragsfertigung in Erstausrüster, Hersteller medizinischer Geräte, Pharmaunternehmen, Biotechnologieunternehmen, Biopharmaunternehmen und Forschungsinstitute segmentiert.
Vertriebskanal
- Einzelhandelsumsätze
- Direkte Ausschreibung
- Sonstiges
Auf der Grundlage der Vertriebskanäle wird der globale Markt für Auftragsfertigung in Direktausschreibungen, Einzelhandelsverkäufe und Sonstiges segmentiert.
Globaler Auftragsfertigungsmarkt – Regionale Analyse/Einblicke
Der globale Markt für Auftragsfertigung wird analysiert und es werden Einblicke in die Marktgröße und Trends nach Produkt, Endbenutzer und Vertriebskanal wie oben angegeben bereitgestellt.
Einige der im Bericht zur Auftragsfertigung abgedeckten Länder sind die USA, Kanada, Mexiko, Deutschland, Frankreich, Italien, Großbritannien, Spanien, Niederlande, Russland, Schweiz, Türkei, Österreich, Norwegen, Ungarn, Litauen, Irland, Polen, Luxemburg, Restliches Europa, Japan, China, Indien, Südkorea, Australien, Singapur, Malaysia, Thailand, Indonesien, Philippinen, Vietnam, Restlicher Asien-Pazifik-Raum, Saudi-Arabien, Südafrika, Vereinigte Arabische Emirate, Israel, Kuwait, Ägypten, Restlicher Naher Osten und Afrika.
Aufgrund des zunehmenden technologischen Fortschritts in den Entwicklungsgebieten wird Nordamerika voraussichtlich dominieren.
Der Länderabschnitt des Berichts enthält auch einzelne marktbeeinflussende Faktoren und Änderungen der Marktregulierung, die die aktuellen und zukünftigen Trends des Marktes beeinflussen. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalysen, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.
Wettbewerbsumfeld und Analyse der Marktanteile im Bereich Auftragsfertigung weltweit
Die Wettbewerbslandschaft des globalen Auftragsfertigungsmarktes liefert Einzelheiten zu den Wettbewerbern. Zu den enthaltenen Einzelheiten gehören Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang sowie Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen auf den Auftragsfertigungsmarkt.
Einige Akteure auf dem Markt sind unter anderem Aenova Group, Thermo Fisher Scientific Inc., EVONIK INDUSTRIES AG, Lonza, Boehringer Ingelheim Biopharmaceuticals GmbH und Catalent, Inc.
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL CONTRACT MANUFACTURING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
4.3 STRATEGIC INITIATIVES:
5 REGULATORY FRAMEWORK
5.1 REGULATORY SCENARIO BY FDA
5.2 REGULATORY SCENARIO IN AUSTRALIA
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING
6.1.3 GLOBAL PRESENCE AND CONNECTED NETWORK
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS
6.2.2 RISK OF CONFIDENTIAL INFORMATION
6.3 OPPORTUNITIES
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
6.4 CHALLENGES
6.4.1 INTELLECTUAL PROPERTY RISKS
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES
7 GLOBAL CONTRACT MANUFACTURING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING
7.2.1 TYPES OF PRODUCTS
7.2.1.1 TABLETS
7.2.1.2 CAPSULES
7.2.1.3 BIOLOGICS
7.2.1.4 SMALL MOLECULE
7.2.1.5 CELL & GENES MANUFACTURING
7.2.1.6 NUTRACEUTICALS
7.2.1.7 OTHERS
7.2.2 TYPE OF SERVICES
7.2.2.1 DRUG DEVELOPMENT SERVICES
7.2.2.2 TABLET MANUFACTURING SERVICES
7.2.2.3 BIOLOGICS API MANUFACTURING
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES
7.2.2.5 OTHERS
7.2.3 BY DOSAGE FORM
7.2.3.1 SOLID FORMULATIONS
7.2.3.2 LIQUID FORMULATIONS
7.2.3.2.1 INJECTABLE
7.2.3.2.2 SYRUPS
7.2.3.3 SEMI-SOLID FORMULATIONS
7.2.3.4 TOPICAL DRUG FORMULATIONS
7.2.3.5 OTHERS
7.3 MEDICAL DEVICE MANUFACTURING
7.3.1 TYPE OF DEVICES
7.3.1.1 SYRINGES AND NEEDLES
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES
7.3.1.4 DISPOSABLES
7.3.1.5 IVD DEVICES
7.3.1.6 CARDIOVASCULAR DEVICES
7.3.1.7 DIABETES CARE DEVICES
7.3.1.8 GENERAL SURGERY DEVICES
7.3.1.9 ORTHOPEDIC DEVICES
7.3.1.10 RESPIRATORY DEVICES
7.3.1.11 OPHTHALMIC DEVICES
7.3.1.12 DENTAL DEVICES
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES
7.3.1.14 LABORATORY EQUIPMENT
7.3.2 TYPE OF SERVICES
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT
7.3.2.2 DEVICE ASSEMBLY
7.3.2.3 REGULATORY ASSISTANCE
7.3.2.4 PACKAGING & LABELLING
7.3.2.5 STERILIZATION SERVICES
7.3.2.6 TRAINING AND VALIDATION
7.3.2.7 QUALITY ASSURANCE
7.3.2.8 OTHERS
7.3.3 BY DEVICE CLASS
7.3.3.1 CLASS I MEDICAL DEVICES
7.3.3.2 CLASS IIA MEDICAL DEVICES
7.3.3.3 CLASS IIB MEDICAL DEVICES
7.3.3.4 CLASS III MEDICAL DEVICES
8 GLOBAL CONTRACT MANUFACTURING MARKET, BY END USER
8.1 OVERVIEW
8.2 PHARMACEUTICAL COMPANIES
8.3 BIOTECHNOLOGY COMPANIES
8.4 BIOPHARMA COMPANIES
8.5 MEDICAL DEVICES COMPANIES
8.6 ORIGINAL EQUIPMENT MANUFACTURER
8.7 RESEARCH INSTITUTES
9 GLOBAL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 RETAIL SALES
9.3 DIRECT TENDER
9.4 OTHERS
10 GLOBAL CONTRACT MANUFACTURING MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 TURKEY
10.3.8 BELGIUM
10.3.9 NETHERLANDS
10.3.10 SWITZERLAND
10.3.11 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 ARGENTINA
10.5.3 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SOUTH AFRICA
10.6.2 SAUDI ARABIA
10.6.3 U.A.E.
10.6.4 EGYPT
10.6.5 ISRAEL
10.6.6 REST OF MIDDLE EAST AND AFRICA
11 GLOBAL CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 AENOVA GROUP
13.1.1 COMPANY SNAPSHOT
13.1.2 COMPANY SHARE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.3 EVONIK INDUSTRIES AG
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 LONZA
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.6 ABBVIE INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENT
13.7 ALMAC GROUP
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 AVID BIOSERVICES, INC.
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT DEVELOPMENT
13.9 BAXTER
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.1 CATALENT, INC
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENT
13.11 FAMAR HEALTH CARE SERVICES
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 JUBILANT PHARMA LIMITED
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENT
13.13 KIMBALL INTERNATIONAL
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 MERCK KGAA
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 NIPR0
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENT
13.16 PFIZER INC
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENT
13.17 RECIPHARM AB.
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENT
13.18 SIEGFRIED HOLDING AG
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENT
13.2 TE CONNECTIVITY
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENT
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 GLOBAL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 GLOBAL OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 GLOBAL CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT)
TABLE 30 NORTH AMERICA NORTH AMERICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP)
TABLE 31 NORTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 37 NORTH AMERICA TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 38 NORTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 42 U.S. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 U.S. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 45 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 46 U.S. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 47 U.S. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 U.S. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 U.S. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 U.S. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 52 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 53 U.S. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 54 U.S. TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 U.S. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 56 U.S. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 U.S. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 58 CANADA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 CANADA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 61 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 62 CANADA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 63 CANADA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 CANADA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 CANADA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 CANADA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 69 CANADA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 70 CANADA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 CANADA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 CANADA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 73 CANADA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 74 MEXICO CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 MEXICO PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 78 MEXICO TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 79 MEXICO BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 MEXICO BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 MEXICO LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 MEXICO MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 84 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 85 MEXICO TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 86 MEXICO TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 MEXICO BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 88 MEXICO CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 MEXICO CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 EUROPE CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 91 EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 EUROPE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 94 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT)
TABLE 95 EUROPE TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP)
TABLE 96 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 EUROPE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 EUROPE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 EUROPE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 100 EUROPE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 101 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 102 EUROPE TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 103 EUROPE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 EUROPE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 EUROPE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 106 EUROPE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 107 GERMANY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 GERMANY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 109 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 110 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 111 GERMANY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 112 GERMANY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 GERMANY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 GERMANY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 GERMANY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 117 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 118 GERMANY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 119 GERMANY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 GERMANY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 GERMANY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 GERMANY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 123 FRANCE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 124 FRANCE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 126 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 127 FRANCE TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 128 FRANCE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 129 FRANCE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 130 FRANCE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 FRANCE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 134 FRANCE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 135 FRANCE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 136 FRANCE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 137 FRANCE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 138 FRANCE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 139 U.K. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 140 U.K. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 141 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 143 U.K. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 144 U.K. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 145 U.K. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 U.K. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 U.K. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 150 U.K. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 151 U.K. TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 152 U.K. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 U.K. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 U.K. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 155 ITALY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 ITALY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 157 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 158 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 159 ITALY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 160 ITALY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 ITALY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 ITALY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 163 ITALY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 164 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 165 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 166 ITALY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 167 ITALY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 ITALY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 169 ITALY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 170 ITALY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 171 SPAIN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 172 SPAIN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 173 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 174 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 175 SPAIN TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 176 SPAIN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 177 SPAIN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 SPAIN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 179 SPAIN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 180 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 181 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 182 SPAIN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 183 SPAIN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 184 SPAIN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 185 SPAIN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 SPAIN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 187 RUSSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 188 RUSSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 189 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 190 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 191 RUSSIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 192 RUSSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 193 RUSSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 194 RUSSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 195 RUSSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 196 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 198 RUSSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 199 RUSSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 200 RUSSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 203 TURKEY CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 204 TURKEY PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 205 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 206 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 207 TURKEY TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 208 TURKEY BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 209 TURKEY BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 210 TURKEY LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 211 TURKEY MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 212 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 213 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 214 TURKEY TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 215 TURKEY TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 216 TURKEY BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 217 TURKEY CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 218 TURKEY CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 219 BELGIUM CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 220 BELGIUM PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 221 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 222 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 223 BELGIUM TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 224 BELGIUM BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 225 BELGIUM BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 226 BELGIUM LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 227 BELGIUM MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 228 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 229 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 230 BELGIUM TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 231 BELGIUM TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 232 BELGIUM BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 233 BELGIUM CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 234 BELGIUM CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 235 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 NETHERLANDS PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 237 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 238 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 239 NETHERLANDS TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 240 NETHERLANDS BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 NETHERLANDS BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 242 NETHERLANDS LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 243 NETHERLANDS MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 244 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 245 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 246 NETHERLANDS TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 247 NETHERLANDS TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 NETHERLANDS BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 249 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 250 NETHERLANDS CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 251 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 252 SWITZERLAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 253 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 255 SWITZERLAND TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 256 SWITZERLAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 257 SWITZERLAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 258 SWITZERLAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 259 SWITZERLAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 260 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 261 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 262 SWITZERLAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 263 SWITZERLAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 264 SWITZERLAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 265 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 266 SWITZERLAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 267 REST OF EUROPE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 268 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 269 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 270 ASIA-PACIFIC PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 271 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 272 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (UNIT)
TABLE 273 ASIA-PACIFIC TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030, 2021-2030 (ASP)
TABLE 274 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 275 ASIA-PACIFIC BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 276 ASIA-PACIFIC LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 277 ASIA-PACIFIC MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 278 ASIA-PACIFIC TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 279 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 280 ASIA-PACIFIC TYPES OF DEVICES IN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 281 ASIA-PACIFIC TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 282 ASIA-PACIFIC BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 283 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 284 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 285 JAPAN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 286 JAPAN PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 287 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 288 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 289 JAPAN TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 290 JAPAN BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 291 JAPAN BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 292 JAPAN LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 293 JAPAN MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 294 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 295 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 296 JAPAN TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 297 JAPAN TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 298 JAPAN BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 299 JAPAN CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 300 JAPAN CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 301 CHINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 302 CHINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 303 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 305 CHINA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 306 CHINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 307 CHINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 308 CHINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 309 CHINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 310 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 311 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 312 CHINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 313 CHINA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 314 CHINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 315 CHINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 316 CHINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 317 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 318 SOUTH KOREA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 319 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 320 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 321 SOUTH KOREA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 322 SOUTH KOREA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 323 SOUTH KOREA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 324 SOUTH KOREA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 325 SOUTH KOREA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 326 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 327 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 328 SOUTH KOREA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 329 SOUTH KOREA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 330 SOUTH KOREA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 331 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 332 SOUTH KOREA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 333 INDIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 334 INDIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 335 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 336 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 337 INDIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 338 INDIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 339 INDIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 340 INDIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 341 INDIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 342 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 343 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 344 INDIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 345 INDIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 346 INDIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 347 INDIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 348 INDIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 349 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 350 AUSTRALIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 351 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 352 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 353 AUSTRALIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 354 AUSTRALIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 355 AUSTRALIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 356 AUSTRALIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 357 AUSTRALIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 358 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 359 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 360 AUSTRALIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 361 AUSTRALIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 362 AUSTRALIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 363 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 AUSTRALIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 365 SINGAPORE CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 366 SINGAPORE PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 367 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 368 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 369 SINGAPORE TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 370 SINGAPORE BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 371 SINGAPORE BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 372 SINGAPORE LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 373 SINGAPORE MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 374 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 375 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 376 SINGAPORE TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 377 SINGAPORE TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 378 SINGAPORE BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 379 SINGAPORE CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 380 SINGAPORE CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 381 THAILAND CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 382 THAILAND PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 383 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 384 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 385 THAILAND TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 386 THAILAND BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 387 THAILAND BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 388 THAILAND LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 389 THAILAND MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 390 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 391 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 392 THAILAND TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 393 THAILAND TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 394 THAILAND BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 395 THAILAND CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 396 THAILAND CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 397 MALAYSIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 398 MALAYSIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 399 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 400 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 401 MALAYSIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 402 MALAYSIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 403 MALAYSIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 404 MALAYSIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 405 MALAYSIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 406 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 407 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 408 MALAYSIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 409 MALAYSIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 410 MALAYSIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 411 MALAYSIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 412 MALAYSIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 413 INDONESIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 INDONESIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 415 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 416 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 417 INDONESIA TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 418 INDONESIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 419 INDONESIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 420 INDONESIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 421 INDONESIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 422 INDONESIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 423 INDONESIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 424 INDONESIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 425 INDONESIA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 426 INDONESIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 427 INDONESIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 428 INDONESIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 429 PHILIPPINES CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 430 PHILIPPINES PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 431 PHILIPPINES TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 432 PHILIPPINES TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 433 PHILIPPINES TYPE OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 434 PHILIPPINES BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 435 PHILIPPINES BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 436 PHILIPPINES LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 437 PHILIPPINES MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 438 PHILIPPINES TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 439 PHILIPPINES TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 440 PHILIPPINES TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 441 PHILIPPINES TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 442 PHILIPPINES BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 443 PHILIPPINES CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 444 PHILIPPINES CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 445 REST OF ASIA-PACIFIC CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 446 SOUTH AMERICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 447 SOUTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 448 SOUTH AMERICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 449 SOUTH AMERICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 450 SOUTH AMERICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 451 SOUTH AMERICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP
TABLE 452 SOUTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 453 SOUTH AMERICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 454 SOUTH AMERICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 455 SOUTH AMERICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 456 SOUTH AMERICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 457 SOUTH AMERICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 458 SOUTH AMERICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 459 SOUTH AMERICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 460 SOUTH AMERICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 461 SOUTH AMERICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 462 SOUTH AMERICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 463 BRAZIL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 464 BRAZIL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 465 BRAZIL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 466 BRAZIL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 467 BRAZIL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 468 BRAZIL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 469 BRAZIL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 470 BRAZIL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 471 BRAZIL MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 472 BRAZIL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 473 BRAZIL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 474 BRAZIL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 475 BRAZIL TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 476 BRAZIL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 BRAZIL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 478 BRAZIL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 479 ARGENTINA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 480 ARGENTINA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 481 ARGENTINA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 482 ARGENTINA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 483 ARGENTINA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 484 ARGENTINA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 485 ARGENTINA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 486 ARGENTINA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 487 ARGENTINA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 488 ARGENTINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 489 ARGENTINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 490 ARGENTINA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 491 ARGENTINA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 492 ARGENTINA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 493 ARGENTINA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 494 ARGENTINA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 495 REST OF SOUTH AMERICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 496 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 497 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 498 MIDDLE EAST AND AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 499 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 500 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, 2021-2030, 2021-2030 (UNIT)
TABLE 501 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP
TABLE 502 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 503 MIDDLE EAST AND AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 504 MIDDLE EAST AND AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 505 MIDDLE EAST AND AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 506 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 507 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 508 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 509 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 510 MIDDLE EAST AND AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 511 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 512 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 513 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 514 SOUTH AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 515 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 516 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 517 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 518 SOUTH AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 519 SOUTH AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 520 SOUTH AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 521 SOUTH AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 522 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 523 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 524 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 525 SOUTH AFRICA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 526 SOUTH AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 527 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 528 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 529 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 530 SAUDI ARABIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 531 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 532 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 533 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 534 SAUDI ARABIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 535 SAUDI ARABIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 536 SAUDI ARABIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 537 SAUDI ARABIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 538 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 539 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 540 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 541 SAUDI ARABIA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 542 SAUDI ARABIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 543 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 544 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 545 UA.E. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 546 UA.E. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 547 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 548 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 549 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 550 UA.E. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 551 UA.E. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 552 UA.E. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 553 UA.E. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 554 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 555 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 556 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 557 UA.E. TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 558 UA.E. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 559 UA.E. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 560 UA.E. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 561 EGYPT CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 562 EGYPT PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 563 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 564 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 565 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 566 EGYPT BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 567 EGYPT BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 568 EGYPT LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 569 EGYPT MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 570 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 571 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 572 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 573 EGYPT TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 574 EGYPT BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 575 EGYPT CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 576 EGYPT CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 577 ISRAEL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 578 ISRAEL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 579 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 580 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 581 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 582 ISRAEL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 583 ISRAEL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 584 ISRAEL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 585 ISRAEL MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 586 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 587 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT)
TABLE 588 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP)
TABLE 589 ISRAEL TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 590 ISRAEL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 591 ISRAEL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 592 ISRAEL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 593 REST OF MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 GLOBAL CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 2 GLOBAL CONTRACT MANUFACTURING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL CONTRACT MANUFACTURING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL CONTRACT MANUFACTURING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL CONTRACT MANUFACTURING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL CONTRACT MANUFACTURING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL CONTRACT MANUFACTURING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL CONTRACT MANUFACTURING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL CONTRACT MANUFACTURING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL CONTRACT MANUFACTURING MARKET: SEGMENTATION
FIGURE 11 RISING TECHNOLOGICAL ADVANCEMENTS AND COST-EFFECTIVENESS OF PHARMACEUTICAL AND MEDICAL PRODUCTS ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL CONTRACT MANUFACTURING MARKET
FIGURE 12 THE PHARMACEUTICAL PRODUCTS MANUFACTURING SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CONTRACT MANUFACTURING MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CONTRACT MANUFACTURING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR CONTRACT MANUFACTURING MARKET MANUFACTURERS IN THE FORECAST PERIOD
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL CONTRACT MANUFACTURING MARKET
FIGURE 16 GLOBAL CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2022
FIGURE 17 GLOBAL CONTRACT MANUFACTURING MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL CONTRACT MANUFACTURING MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 19 GLOBAL CONTRACT MANUFACTURING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 GLOBAL CONTRACT MANUFACTURING MARKET: BY END USER, 2022
FIGURE 21 GLOBAL CONTRACT MANUFACTURING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 22 GLOBAL CONTRACT MANUFACTURING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 23 GLOBAL CONTRACT MANUFACTURING MARKET: BY END USER, LIFELINE CURVE
FIGURE 24 GLOBAL CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 25 GLOBAL CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 27 GLOBAL CONTRACT MANUFACTURING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 28 GLOBAL CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 29 GLOBAL CONTRACT MANUFACTURING MARKET: BY REGION (2022)
FIGURE 30 GLOBAL CONTRACT MANUFACTURING MARKET: BY REGION (2023 & 2030)
FIGURE 31 GLOBAL CONTRACT MANUFACTURING MARKET: BY REGION (2023 & 2030)
FIGURE 32 GLOBAL CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 33 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: SNAPSHOT (2022)
FIGURE 34 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2022)
FIGURE 35 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 36 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 37 NORTH AMERICA MEDICAL TRANSPORT BOXES MARKET: BY PRODUCT (2023-2030)
FIGURE 38 EUROPE CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 43 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 44 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 45 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 46 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 47 ASIA-PACIFIC CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 48 SOUTH AMERICA CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 49 SOUTH AMERICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 50 SOUTH AMERICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 51 SOUTH AMERICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 52 SOUTH AMERICA CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 53 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: SNAPSHOT (2022)
FIGURE 54 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022)
FIGURE 55 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 56 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 57 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET: BY PRODUCT (2023-2030)
FIGURE 58 GLOBAL CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
FIGURE 59 NORTH AMERICA CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
FIGURE 60 EUROPE CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
FIGURE 61 AISA-PACIFIC CONTRACT MANUFACTURING MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
